Trial Profile

A clinical trial of GT 1708F in China

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 23 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs GT 1708F (Primary)
Indications Acute myeloid leukaemia; Haematological malignancies; Leukaemia
Focus Adverse reactions

Most Recent Events

28 Aug 2023 According to a Kintor Pharmaceutical Limited media release, data from this study was presented at AACR 2023
28 Aug 2023 Results presented in the Kintor Pharmaceutical Media Release.
28 Aug 2023 According to a Kintor Pharmaceutical Limited media release,Status changed to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com